Product Information |
|
Registration Number |
DR-XY48310
|
Generic Name |
Pegaspargase
|
Brand Name |
Oncaspar
|
Dosage Strength |
750 U/mL
|
Dosage Form |
Powder for Solution for Injection/ Infusion
(IV/IM)
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
Antineoplastic
|
Packaging |
Type I clear glass vial with gray chlorobutyl rubber
stopper with aluminum seal and yellow flip-off cap
|
Manufacturer |
Lyophilization Services of New England Inc.
|
Country of Origin |
United States of America
|
Trader |
Les Laboratoires Servier
|
Importer |
Servier Philippines, Inc.
|
Distributor |
Zuellig Pharma Corporation
|
Application Type |
Monitored Release
|
Issuance Date |
23 August 2022
|
Expiry Date |
23 August 2027
|